Not approved (research only)Synthetic gastric peptide fragmentTissue repair research
Pentadecapeptide BPC-157
"Pentadecapeptide" here refers to BPC-157, the 15-amino-acid synthetic peptide studied in animal models of tissue injury.
What is Pentadecapeptide BPC-157?
"Pentadecapeptide" here refers to BPC-157, the 15-amino-acid synthetic peptide studied in animal models of tissue injury. Pentadecapeptide BPC-157 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Key takeaways
- Pentadecapeptide BPC-157 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
- PubMed indexes 173 papers on Pentadecapeptide BPC-157 (0 tagged as clinical trials) as of October 19, 2026.
- No vendor in our directory listed Pentadecapeptide BPC-157 when we checked.
Regulatory & access status
Pentadecapeptide BPC-157 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on Pentadecapeptide BPC-157?
PubMed indexes 173 papers mentioning Pentadecapeptide BPC-157 in the title or abstract, 56 of them from the last five years and 0 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. — J Orthop Res, 2003
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. — J Appl Physiol (1985), 2011
- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. — Front Pharmacol, 2021 · review
- Pentadecapeptide BPC 157 and the central nervous system. — Neural Regen Res, 2022 · review
- Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral Pathways. — Curr Med Chem, 2023
- BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. — Curr Pharm Des, 2018 · review
What the evidence does not show
- Paper counts measure research attention, not whether Pentadecapeptide BPC-157 works or is safe.
- No clinical trial in humans is tagged in PubMed under this name.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
Research suppliers that list Pentadecapeptide BPC-157
None of the vendors in our directory listed Pentadecapeptide BPC-157 in their public catalog when we checked. The vendor directory records what each vendor publishes about testing.
Pentadecapeptide BPC-157 reconstitution math
Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.
Pentadecapeptide BPC-157 FAQ
Is Pentadecapeptide BPC-157 FDA-approved?
Pentadecapeptide BPC-157 is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
Is Pentadecapeptide BPC-157 safe?
There are no published human safety trials of Pentadecapeptide BPC-157 that we could find. Products sold as "research use only" have no FDA review of purity, sterility or dose, and are not for human use.
How much research is there on Pentadecapeptide BPC-157?
PubMed indexes 173 papers on Pentadecapeptide BPC-157 (0 tagged as clinical trials) as of October 19, 2026.
Who sells Pentadecapeptide BPC-157?
None of the vendors in our directory listed it when we checked.
Related compounds
TB-500BPC-157BPC-157 + TB-500 blendTri-heal blendGLOW blendGHK-CuKLOW blendKPVAll tissue repair & recovery